A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-16
DOI
10.1002/cncr.32406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The relationship between muscle mass and function in cancer cachexia
- (2018) Michael I. Ramage et al. Current Opinion in Supportive and Palliative Care
- Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer
- (2018) Tateaki Naito et al. Journal of Cachexia Sarcopenia and Muscle
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
- (2017) Tora S. Solheim et al. Journal of Cachexia Sarcopenia and Muscle
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
- (2016) Koichi Takayama et al. SUPPORTIVE CARE IN CANCER
- Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
- (2016) Koichi Takayama et al. SUPPORTIVE CARE IN CANCER
- Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
- (2016) Masaaki Konishi et al. Journal of Cachexia Sarcopenia and Muscle
- Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
- (2015) José M Garcia et al. LANCET ONCOLOGY
- Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved
- (2015) Ji-an Chen et al. Journal of Cachexia Sarcopenia and Muscle
- MECHANISMS IN ENDOCRINOLOGY: Regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
- (2014) Kristy M Heppner et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of Cachexia: An Overview of Recent Developments
- (2014) Stephan von Haehling et al. Journal of the American Medical Directors Association
- Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014
- (2014) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Clinical evaluation and optimal management of cancer cachexia
- (2013) Albert Tuca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
- (2013) R. Northrup et al. SUPPORTIVE CARE IN CANCER
- Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States
- (2013) Lei Chen et al. BMC Geriatrics
- The potential of ghrelin in the treatment of cancer cachexia
- (2012) Josep M Argilés et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
- (2012) José M. Garcia et al. SUPPORTIVE CARE IN CANCER
- Ghrelin and cachexia: Will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?
- (2011) Mark D. DeBoer MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Understanding the functional significance of ghrelin processing and degradation
- (2011) Motoyasu Satou et al. PEPTIDES
- Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients
- (2010) Amanda Hill et al. CLINICAL NUTRITION
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
- (2009) Niels Møller et al. ENDOCRINE REVIEWS
- The cancer anorexia-cachexia syndrome: myth or reality?
- (2009) Wael Lasheen et al. SUPPORTIVE CARE IN CANCER
- Regulation of muscle mass by growth hormone and IGF-I
- (2008) C P Velloso BRITISH JOURNAL OF PHARMACOLOGY
- Cachexia: A new definition
- (2008) William J. Evans et al. CLINICAL NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now